{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:57:55Z","timestamp":1790891875459,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06790-7","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:16:03Z","timestamp":1790889363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating tumour DNA and extrachromosomal DNA in prostate and bladder cancer: biology, clinical applications and future perspectives"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8069-5444","authenticated-orcid":false,"given":"Jihane","family":"Elmasmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-3931","authenticated-orcid":false,"given":"Axel S.","family":"Merseburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"3","key":"6790_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263 Epub 2024 Apr 4. PMID:38572751","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"6790_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152589","volume":"17","author":"SA Kopytov","year":"2025","unstructured":"Kopytov SA, Sagitova GR, Guschin DY, Egorova VS, Zvyagin AV, Rzhevskiy AS (2025) Circulating tumor DNA in prostate cancer: a dual perspective on early detection and advanced disease management. Cancers (Basel) 17(15):2589. https:\/\/doi.org\/10.3390\/cancers17152589","journal-title":"Cancers (Basel)"},{"issue":"7867","key":"6790_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","volume":"595","author":"T Powles","year":"2021","unstructured":"Powles T, Assaf ZJ, Davarpanah N et al (2021) ctDNA guiding adjuvant immunotherapy in urothelial carcinoma. Nature 595(7867):432\u2013437. https:\/\/doi.org\/10.1038\/s41586-021-03642-9","journal-title":"Nature"},{"issue":"9","key":"6790_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim H, Nguyen NP, Turner K et al (2020) Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat Genet 52(9):891\u2013897. https:\/\/doi.org\/10.1038\/s41588-020-0678-2. Epub 2020 Aug 17. PMID:32807987","journal-title":"Nat Genet"},{"issue":"7784","key":"6790_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-019-1763-5","volume":"575","author":"S Wu","year":"2019","unstructured":"Wu S, Turner KM, Nguyen N et al (2019) Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature 575(7784):699\u2013703. https:\/\/doi.org\/10.1038\/s41586-019-1763-5","journal-title":"Nature"},{"key":"6790_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104898","volume":"215","author":"H Li","year":"2025","unstructured":"Li H, Lu J, Bian Y, Gao Y, Wang L (2025) Extrachromosomal DNA in cancer: molecular mechanisms underlying oncogene amplification and tumor heterogeneity. Crit Rev Oncol Hematol 215:104898. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104898","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"6790_CR7","doi-asserted-by":"publisher","first-page":"10648","DOI":"10.1038\/s41467-024-54847-1","volume":"15","author":"TP Knutson","year":"2024","unstructured":"Knutson TP, Luo B, Kobilka A et al (2024) AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. Nat Commun 15(1):10648. https:\/\/doi.org\/10.1038\/s41467-024-54847-1. PMID:39663356","journal-title":"Nat Commun"},{"issue":"12","key":"6790_CR8","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1158\/1078-0432.CCR-25-2779","volume":"32","author":"JC Valent\u00edn L\u00f3pez","year":"2026","unstructured":"Valent\u00edn L\u00f3pez JC, Yu C, Knutson TP et al (2026) Evolution of AR and non-AR alterations in ctDNA of patients with metastatic prostate cancer treated in the phase III Alliance A031201 trial. Clin Cancer Res 32(12):2413\u20132427. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-2779","journal-title":"Clin Cancer Res"},{"issue":"13","key":"6790_CR9","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.7150\/thno.99563","volume":"14","author":"W Lv","year":"2024","unstructured":"Lv W, Pan X, Han P et al (2024) Extrachromosomal circular DNA orchestrates genome heterogeneity in urothelial bladder carcinoma. Theranostics 14(13):5102\u20135122. https:\/\/doi.org\/10.7150\/thno.99563","journal-title":"Theranostics"},{"issue":"1\u20132","key":"6790_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","volume":"164","author":"MW Snyder","year":"2016","unstructured":"Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J (2016) Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 164(1\u20132):57\u201368. https:\/\/doi.org\/10.1016\/j.cell.2015.11.050","journal-title":"Cell"},{"issue":"11","key":"6790_CR11","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1073\/pnas.1501321112","volume":"112","author":"F Mouliere","year":"2015","unstructured":"Mouliere F, Rosenfeld N (2015) Circulating tumor-derived DNA is shorter than somatic DNA in plasma. Proc Natl Acad Sci USA 112(11):3178\u20133179. https:\/\/doi.org\/10.1073\/pnas.1501321112. Epub 2015 Mar 2. PMID:25733911","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6790_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4921","author":"F Mouliere","year":"2018","unstructured":"Mouliere F, Chandrananda D, Piskorz AM et al (2018) Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aat4921","journal-title":"Sci Transl Med"},{"issue":"224","key":"6790_CR13","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra24. https:\/\/doi.org\/10.1126\/scitranslmed.3007094. PMID:24553385","journal-title":"Sci Transl Med"},{"issue":"9","key":"6790_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA et al (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14(9):985\u201390. https:\/\/doi.org\/10.1038\/nm.1789","journal-title":"Nat Med"},{"issue":"12","key":"6790_CR15","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","volume":"25","author":"P Razavi","year":"2019","unstructured":"Razavi P, Li BT, Brown DN et al (2019) High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. Nat Med 25(12):1928\u20131937. https:\/\/doi.org\/10.1038\/s41591-019-0652-7","journal-title":"Nat Med"},{"issue":"4","key":"6790_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2026.102545","volume":"24","author":"D Ye","year":"2026","unstructured":"Ye D, Zhao Y, Yang L et al (2026) Prognostic significance of circulating tumor DNA in metastatic prostate cancer: a systematic review and meta-analysis. Clin Genitourin Cancer 24(4):102545. https:\/\/doi.org\/10.1016\/j.clgc.2026.102545","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"6790_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J et al (2017) Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 17(4):223\u2013238. https:\/\/doi.org\/10.1038\/nrc.2017.7","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"6790_CR18","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa2511885","volume":"393","author":"T Powles","year":"2025","unstructured":"Powles T, Kann AG, Castellano D et al (2025) ctDNA-guided adjuvant atezolizumab in muscle-invasive bladder cancer. N Engl J Med 393(24):2395\u20132408. https:\/\/doi.org\/10.1056\/NEJMoa2511885","journal-title":"N Engl J Med"},{"issue":"5","key":"6790_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.annonc.2025.12.018","volume":"37","author":"L Dyrskj\u00f8t","year":"2026","unstructured":"Dyrskj\u00f8t L, Birkenkamp-Demtr\u00f6der K, Nordentoft I et al (2026) ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial. Ann Oncol 37(5):712\u2013724. https:\/\/doi.org\/10.1016\/j.annonc.2025.12.018","journal-title":"Ann Oncol"},{"issue":"7402","key":"6790_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(65)90131-5","volume":"2","author":"D Cox","year":"1965","unstructured":"Cox D, Yuncken C, Spriggs AI (1965) Minute chromatin bodies in malignant tumours of childhood. Lancet 2(7402):55\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(65)90131-5. PMID:14304929","journal-title":"Lancet"},{"issue":"8037","key":"6790_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","volume":"635","author":"C Bailey","year":"2024","unstructured":"Bailey C, Pich O, Thol K et al (2024) Origins and impact of extrachromosomal DNA. Nature 635(8037):193\u2013200. https:\/\/doi.org\/10.1038\/s41586-024-08107-3","journal-title":"Nature"},{"issue":"6778","key":"6790_CR22","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.ado0977","volume":"390","author":"K Krupina","year":"2025","unstructured":"Krupina K, Goginashvili A, Baughn MW et al (2025) Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes. Science 390(6778):1156\u20131163. https:\/\/doi.org\/10.1126\/science.ado0977","journal-title":"Science"},{"key":"6790_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-genom-120821-100535","volume":"23","author":"V Bafna","year":"2022","unstructured":"Bafna V, Mischel PS (2022) Extrachromosomal DNA in Cancer. Annu Rev Genomics Hum Genet 23:29\u201352. https:\/\/doi.org\/10.1146\/annurev-genom-120821-100535. Epub 2022 May 24. PMID:35609926","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"11","key":"6790_CR24","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41588-024-01949-7","volume":"56","author":"H Kim","year":"2024","unstructured":"Kim H, Kim S, Wade T et al (2024) Mapping extrachromosomal DNA amplifications during cancer progression. Nat Genet 56(11):2447\u20132454. https:\/\/doi.org\/10.1038\/s41588-024-01949-7","journal-title":"Nat Genet"},{"issue":"7890","key":"6790_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41586-021-04116-8","volume":"600","author":"KL Hung","year":"2021","unstructured":"Hung KL, Yost KE, Xie L et al (2021) ecDNA hubs drive cooperative intermolecular oncogene expression. Nature 600(7890):731\u2013736. https:\/\/doi.org\/10.1038\/s41586-021-04116-8. Epub 2021 Nov 24. PMID:34819668","journal-title":"Nature"},{"issue":"6166","key":"6790_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1241328","volume":"343","author":"DA Nathanson","year":"2014","unstructured":"Nathanson DA, Gini B, Mottahedeh J et al (2014) Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science 343(6166):72\u201376. https:\/\/doi.org\/10.1126\/science.1241328. Epub 2013 Dec 5. PMID:24310612","journal-title":"Science"},{"key":"6790_CR27","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-1532","author":"W Lv","year":"2025","unstructured":"Lv W, Zeng Y, Li C et al (2025) Spatial-Temporal Diversity of Extrachromosomal DNA Shapes Urothelial Carcinoma Evolution and Tumor-Immune Microenvironment. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-1532. Epub ahead of print. PMID:40062518","journal-title":"Cancer Discov"},{"issue":"1","key":"6790_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41467-018-08200-y","volume":"10","author":"V Deshpande","year":"2019","unstructured":"Deshpande V, Luebeck J, Nguyen ND et al (2019) Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun 10(1):392. https:\/\/doi.org\/10.1038\/s41467-018-08200-y. PMID:30674876","journal-title":"Nat Commun"},{"issue":"1","key":"6790_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41467-018-03369-8","volume":"9","author":"HD M\u00f8ller","year":"2018","unstructured":"M\u00f8ller HD, Mohiyuddin M, Prada-Luengo I et al (2018) Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. Nat Commun 9(1):1069. https:\/\/doi.org\/10.1038\/s41467-018-03369-8. PMID:29540679","journal-title":"Nat Commun"},{"key":"6790_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad045","author":"A Zivanovic","year":"2023","unstructured":"Zivanovic A, Miller JT, Munro SA et al (2023) Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer. NAR Cancer. https:\/\/doi.org\/10.1093\/narcan\/zcad045","journal-title":"NAR Cancer"},{"key":"6790_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx118","author":"AW Wyatt","year":"2017","unstructured":"Wyatt AW, Annala M, Aggarwal R et al (2017) Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx118","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"6790_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H et al (2014) AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 371(11):1028\u201338. https:\/\/doi.org\/10.1056\/NEJMoa1315815","journal-title":"N Engl J Med"},{"issue":"16","key":"6790_CR33","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1158\/1078-0432.CCR-21-1625","volume":"27","author":"M Annala","year":"2021","unstructured":"Annala M, Taavitsainen S, Khalaf DJ et al (2021) Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clin Cancer Res 27(16):4610\u20134623. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1625. Epub 2021 Jun 3. PMID:34083234","journal-title":"Clin Cancer Res"},{"issue":"7921","key":"6790_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-022-04975-9","volume":"608","author":"C Herberts","year":"2022","unstructured":"Herberts C, Annala M, Sipola J et al (2022) Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer. Nature 608(7921):199\u2013208. https:\/\/doi.org\/10.1038\/s41586-022-04975-9. PMID:35859180","journal-title":"Nature"},{"issue":"6","key":"6790_CR35","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-18-1943","volume":"25","author":"B De Laere","year":"2019","unstructured":"De Laere B, Oeyen S, Mayrhofer M et al (2019) TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res 25(6):1766\u20131773. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1943. Epub 2018 Sep 12. PMID:30209161","journal-title":"Clin Cancer Res"},{"key":"6790_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217875","volume":"628","author":"M Zhang","year":"2025","unstructured":"Zhang M, Xu Z, Cao Y et al (2025) Analysis and characterization of extrachromosomal circular DNA in prostate cancer: potential biomarker discovery from urine, plasma, and tumor samples. Cancer Lett 628:217875. https:\/\/doi.org\/10.1016\/j.canlet.2025.217875","journal-title":"Cancer Lett"},{"issue":"8037","key":"6790_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-024-07802-5","volume":"635","author":"J Tang","year":"2024","unstructured":"Tang J, Weiser NE, Wang G et al (2024) Enhancing transcription-replication conflict targets ecDNA-positive cancers. Nature 635(8037):210\u2013218. https:\/\/doi.org\/10.1038\/s41586-024-07802-5","journal-title":"Nature"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06790-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06790-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06790-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:16:04Z","timestamp":1790889364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06790-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6790"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06790-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lectures, speaker engagements and honoraria:Ambu, Amgen, Apogepha, AstraZeneca, Astellas, Bayer, Bristol Myers Squibb, Eisai, EUSA Pharma, FARCO-PHARMA, Ferring, Hexal\/Sandoz, Ipsen, Johnson & Johnson\/Janssen, MedUpdate, Merck Serono, MSD, Novartis, Pfizer, Recordati, Roche, Solution akademie, Springer Healthcare and Takeda.Consulting and advisory activities:Ambu, Amgen, Apogepha, AstraZeneca, Astellas, Bayer, Bristol Myers Squibb, Eisai, EUSA Pharma, FARCO-PHARMA, Ferring, Hexal\/Sandoz, Ipsen, Johnson & Johnson\/Janssen, MedUpdate, Merck Serono, MSD, Novartis, Pfizer, Recordati, Roche and Takeda.Research funding and clinical trials:AstraZeneca, Astellas, Bayer, Bristol Myers Squibb, Eisai, EUSA Pharma, Ipsen, Johnson & Johnson\/Janssen, Merck Serono, MSD, Novartis, Pfizer, Recordati, Roche and Takeda. Editorial position : Associate Editor of World Journal of Urology","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable; this review is based exclusively on published literature and did not involve human participants or animals.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A large language model was used to support literature organisation and language editing. The authors reviewed, verified and edited all content and take full responsibility for the integrity and accuracy of the manuscript.","order":3,"name":"Ethics","label":"Use of large language models\/AI","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"722"}}